Big Data and The Future of R&D Management
Big Data and The Future of R&D Management
Big Data and The Future of R&D Management
To cite this article: Michael Blackburn, Jeffrey Alexander, J. David Legan & Diego Klabjan (2017)
Big Data and the Future of R&D Management, Research-Technology Management, 60:5, 43-51
Download by: [Sam Houston State University] Date: 09 October 2017, At: 21:26
IRI RESEARCH
none defined
OVERVIEW: This study explores the concept of big data and whether, and to what extent, it might affect R&D management
in the future. Through extensive discussions to dissect the nature of big data and to achieve a common understanding of
Downloaded by [Sam Houston State University] at 21:26 09 October 2017
what it represents, a research framework was constructed to analyze the impact of big data based on its potential to inform,
enable, and transform or disrupt R&D management across four dimensions: strategy, people, technology, and process
integration. A literature review, interviews with experts, and case studies of organizations using big data demonstrate that
this phenomenon will have significant implications for R&D and innovation management, although the nature and extent
of that impact is somewhat uneven among different industry sectors.
Big data is increasingly pervasive, changing how we big data is so pervasive and well-established that it is
understand the world. Researchers have used big data, no longer “emerging” (Sharwood 2015). Clearly, all R&D
gathered from social media streams, sensors embedded in organizations will need to deal with big data sooner or later.
consumer products, and elsewhere, to identify problems Organizations are no longer asking whether or not they
with newly launched products before they escalate and to should exploit big data for competitive advantage—
develop ideas for enhancements to existing products based they are determining what to do with the big data that is
on their observed performance. As technology has enabled already part of the operating environment.
more organizations to access and analyze big data, it has But although it offers intriguing possibilities for new
become more common. In fact, market research firm approaches to R&D, new business models, even new
Gartner Group recently removed big data from its annual markets, for many, as Stephen Hoover has noted, “Big data
“hype cycle” chart of emerging technologies, arguing that isn’t a solution—it’s a problem” (Hoover 2015). The many
Michael Blackburn is the portfolio/program leader for Global Research innovation; client collaboration; and people development in large and small
Management at Cargill. Mike joined Cargill’s corn milling business in businesses. He managed the corporate microbiology laboratory and
1980 and held multiple roles in Quality Assurance Management and initiated a program of microbial modeling and new technology evaluation
Research and Development Management. In 2001, he became director of at Nabisco. At Kraft, he worked in an open innovation model with
scientific resources, overseeing locations in the United States and Europe. universities and other external partners to find, evaluate, and develop food
He became Enterprise Architecture Modeling Lead in 2008 as part of safety and preservation technologies to protect consumers, especially
Cargill’s program to improve business processes and moved to his current those that offer alternatives to artificial preservatives. He has a BSc in
role in 2011. He has a BS in biology and chemistry from Wright State applied biology from the University of Bath and a PhD in food technology
University, an MS in engineering management from the University of from the University of Reading. [email protected]
Massachusetts, and a ThD from Christian Leadership University. Diego Klabjan is a professor at Northwestern University. He joined
[email protected] Northwestern’s faculty as an assistant professor in 2001 and was promoted
Jeffrey Alexander is senior manager, innovation policy, at RTI to full professor in 2012. His research is focused on applying machine
International. He has more than 25 years of experience conducting in-depth learning in the areas of health care, transportation, and finance. He has
analyses of high-technology markets, tracking and evaluating R&D served as an assistant professor in the University of Illinois’s Department
strategies and policies, and advising national and regional governments of Mechanical and Industrial Engineering and the Department of Civil and
on technology program funding and implementation. He is coauthor of Environmental Engineering at the University of Illinois at Urbana-
Global and Local Knowledge: Glocal Transatlantic Public-Private Partner- Champaign. He is the recipient of the INFORMS 2000 Transportation
ships for Research & Technology Development (Palgrave 2006). He holds Science Dissertation Award and the Preseren’s Award, given by the
a PhD in the management of science, technology, and innovation from University of Ljublana, Slovenia, for the outstanding undergraduate thesis.
the George Washington University and a BA in international relations from [email protected]
Stanford University, where he completed the honors program in science, DOI: 10.1080/08956308.2017.1348135
technology, and society. [email protected] Copyright © 2017, Industrial Research Institute.
J. David Legan is an experienced technical leader with an international Published by Taylor & Francis. All rights reserved.
record of strategic project, team, and idea leadership; breakthrough
understanding of the trade-offs between different options; questions, reflecting a broad range of understanding of
it may improve the quality of decisions by integrating more and involvement with big data in participants’ operations.
factors and more complex interactions than humans are Some members reported explorations of big data involving
capable of processing unaided. One area where prescriptive large research programs and dedicated groups; other
analytics is making inroads is in computer-assisted diagno- organizations were still trying to determine the meaning
sis. In these systems, a physician enters observations about of big data and why they should be concerned with it. With
a patient into an engine that then scans the medical litera- this diversity of understanding and utilization of big data,
ture to identify diseases or disorders that might be generat- the first challenge was to develop a common understanding
ing those symptoms. The system can then analyze all of of what big data is and identify an approach to frame the
those inputs to identify the procedures or treatments most discussion of its likely impacts on R&D.
likely to be effective in that particular case (Haftner 2012). That approach emerged from early literature analysis
Big data analytics will inevitably have an impact on and the IRI’s 2015 Winter ROR Meeting workshop as we
management. As big data gains a foothold, management worked to define the scope of the Digitalization project.
decisions based purely on intuition or experience are We identified three kinds of impacts—inform, enable, and
increasingly being regarded as suspect (Economist transform/disrupt—across four key elements of R&D
Intelligence Unit 2012). LaValle and colleagues (2010) operations—strategy, people, technology, and process
report that, in their study, “top-performing organizations (Table 1). The impacts align with innovation frameworks,
use analytics five times more than lower performers.” The which typically define projects in terms of incremental,
challenge to management is that decisions about strategy adjacent, and transformational outcomes. The elements of
and operations become more complex as the complexity people, process, and technology have long been used in
of the data that must be considered increases (Zhao, Fan, change management (Maltaverne 2015); strategy was
and Hu 2014). The question is whether R&D management added because of its importance to R&D.
is prepared to cope with this changing environment. To begin to answer the questions raised by this way of
The rise of big data, and big data tools, then, will present thinking, we looked to interviews with thought leaders,
challenges and opportunities across the full range of R&D further review of the literature, and requests for examples
management responsibilities and activities. Going forward, from attendees at IRI meetings. Ultimately, we hoped to
it will increasingly inform innovation and the process gather a set of examples and cases that would help demon-
a company uses to execute innovation, enable new strate how big data is being used now and illuminate how it
approaches to R&D, and transform the practice of R&D. is likely to change R&D practices going forward.
Some of these changes—particularly those with regard to We began the study by interviewing eight thought
how big data informs or enables innovation—may be leaders who are recognized by IRI members as leaders in
largely incremental, driving toward accelerating R&D while understanding and using big data, to help gain an under-
driving down cost and risks. Larger challenges lie in the standing of what big data applications look like and how
potential for big data and analytics to disrupt or transform big data is likely to develop in the future. The hour-long
current business models, for instance, as nontraditional interviews were recorded and summarized, then reviewed
players find ways to use big data to dislodge established by the group to extract key points. These interviews
market leaders, or established leaders radically reshape provided insights that helped refine the framework and
their structures and processes to make better use of big structure our questions for the case studies.
data and potentially remake their businesses, rendering We then began to gather examples of the application
competitors’ models obsolete. of big data in R&D that we could align to the framework.
How will
Big Data
enable new
approaches
to R&D/
innovation?
How will
Downloaded by [Sam Houston State University] at 21:26 09 October 2017
Big Data
transform/
disrupt R&D/
innovation?
integration. However, within a given segment, there can be have also invested in big data capabilities in sales and
a broad range of understanding and execution. While there marketing to provide leads and insights through, for
are many examples of big data enabling new R&D example, monitoring social media feeds. These data,
approaches across industry segments, government and the combined with data from consumer calls and external
more technology-focused industry segments are ahead in databases such as patents and scientific literature, generate
this regard. This same group leads in the use of big data to insights for R&D in the form of recommendations for
transform or disrupt R&D. product improvements.
For Eastman and consumer goods companies, big data
Inform provides both marketing and innovation insight. In
Insights provided by big data can inform both the kinds of industrial manufacturing, big data also plays more than
innovations an organization pursues and the process it one role—both providing a customer service and feeding
uses to produce new products and services. Big data can back into companies’ innovation plans. The increasingly
contribute to opportunity assessment, project selection, common incorporation of sensors and the Internet of
and even identification of potentially fruitful incremental Things (IoT) into industrial products provides performance
product improvements. data that companies use to support the provision of services
For instance, Eastman Chemical Company engaged in a to existing customers. That performance data can also help
collaboration with North Carolina State University to apply identify opportunities to improve product performance,
big data to gain insight into 3D printing technology and heighten efficiency, or fill new customer needs. In other
the market environment. The project collected consumer words, even as data supports an existing product, it gives
responses to and attitudes toward relevant Eastman pro- R&D information about what the next generation of
ducts and competitors’ products from social media and used projects in the portfolio should look like.
unstructured text analytics to identify consumer concerns If big data is to inform R&D, new skills and competencies
and needs. Ultimately, the analysis highlighted the envir- will be needed. The thought leaders we interviewed noted
onmental impact of the products as a key consumer that analysts need to be familiar both with data analytics
concern. Thus, big data delivered rapid opportunity assess- and with the underlying business or research question
ment and identified a lucrative, underserved market space being addressed, calling to mind the pi-shaped skill set
that could be addressed by Eastman’s capabilities. described by Alexander, Blackburn, and Legan (2015).
Eastman’s use of big data spanned the boundary These observations, our interviewees said, point to a
between marketing and R&D; consumer goods companies need for changes in both hiring and training in R&D
search across all literature and relevant databases and even process—in order to keep up, or face the risk of being dis-
internal document repositories to identify information that rupted by competitors who deploy big data to drive new
is pertinent to a researcher-defined query. For example, product development, streamline R&D to get to market
Meta.com offers a product that helps researchers learn from faster, and move into new markets.
the vast amount of research being produced around the Some industries are already seeing these forces in
world each day. play, forcing organizations to look not only at what work
One basic use of big data tools to enable R&D is to manage is being done but also at how that work is structured.
the information needed to support innovation. For instance, One interviewee told us that the US intelligence
consulting firm Decernis maintains a very large database of community has responded by moving from a hierarchical
worldwide regulations pertaining to food, cosmetics, over- organizational model to a network model. By aggregating
the-counter pharmaceuticals, medical devices, packaging, large central data repositories, accessible through a secure
and more, with all the raw materials used in these areas network using a standardized suite of tools, intelligence
catalogued. The data are translated into 40 languages. This agencies can perform multiple analyses simultaneously
database permits the R&D organizations that use the firm’s and collaborate organically, instead of routing all analytical
service to formulate products with greater confidence that work to one organization. This approach allows the
the products will be accepted by regulatory agencies in community to process more data and exploit its insights
the target market; it also provides insight into potential more efficiently.
regulatory issues before they cause operational difficulties. Big data is also changing the way organizations pursue
Another challenge in R&D management is managing open innovation. In an approach pioneered by Procter
unexpected events that impact a company’s products. One & Gamble in the early 2000s, companies form open
consumer goods company we spoke to monitors social media networks of individual and organizational collaborators
streams when a new product is launched, using analytics to that share information, gleaning insights from widely
gauge consumer reaction and monitor for unexpected issues. distributed resources that can then be applied to R&D
In one case, a packaging issue was identified by comments in (Kastelle 2012; Ozkan 2015). This approach allowed
social media; the company’s R&D organization was able to P&G to integrate external resources into its innovation
create a correction and put it in place before any complaints process; ultimately, the company was able to streamline
were received in the company’s call center. IBM’s Watson its innovation infrastructure and reduce R&D spending.
has also been used to monitor social media streams for However, to accomplish this, P&G had to develop ways
product “scares” or potential recalls. to manage and screen the flow of ideas and knowledge.
For big data to enable R&D, we observe from those who This is an example of a transformation and disruption of
have embraced big data, R&D management must be R&D through the collection of ideas from a large group
looking for new, more efficient ways to carry out research of external contributors, supported by a big data analytics
solution.
Other organizations are deploying big data to support
approaches to R&D that would not have been feasible
without big data and analytics. DARPA’s Big Mechanism
If big data is to inform R&D, new skills and
program, for instance, seeks to accelerate cancer research
competencies will be needed. by leveraging the entire research literature (Cohen 2015).
The project is using big data tools to “read” every scientific
article related to cancer, extract all instances suggesting
involving thousands of patients; often, those trials docu- however, this process is moving to virtual screening, in
ment inherently variable responses to a given compound which computer models examine millions of compounds
because of genetic and physiological diversity across the for potential interaction with targets and identify the
patient population. These variations can obscure the true most promising ones. Only a small subset undergoes
outcome of a trial and make it difficult to map a new traditional biological screening (Storrs 2015). This
drug’s actual effects. To deal with this challenge, pharma approach allows more potential molecules to be identi-
companies have developed very sophisticated data fied more quickly and at lower cost, bringing drugs to
analysis capabilities. clinical trial and eventually to market more quickly.
However, the industry has not definitively solved the big
data problem. Traditional pharmaceutical research has . Transforming and disrupting. Extrapolating only a little, it
become increasingly less productive over the past two is not hard to see how the revolution in the availability
decades, at least in part because of a “lack of data or lack of genomic data and data analysis tools could change the
of appropriate analysis of the available data” (Tormay nature of pharmaceutical discovery by permitting the
2015, 88). At the same time, certain kinds of data have identification of compounds with high efficacy in
rapidly gone from being unavailable or difficult to access targeted genetic groups, even if that efficacy cannot be
to being overabundant, largely driven by advances in distinguished from a placebo when compared across
genome sequencing technology and a concomitant reduc- the general population. Bernie Meyerson, Chief Innov-
tion in the costs associated with gene sequencing. The ation Officer at IBM and one of the preeminent thinkers
Human Genome Project announced its first draft sequence on big data, suggested in his interview with us that
in 2000 and its first finished genome in 2003; this first effort health care is where big data will have the greatest
took more than 10 years and cost approximately $2.7 billion societal impact (at least in the United States) and that
with 20 different institutions collaborating (National Human the opportunities presented by the application of big
Genome Research Institute 2003). Today, a human genome data in pharmaceuticals will ultimately be a contributor
can be sequenced in a matter of hours for around $1,000; to that outcome.
one high-throughput sequencer can deliver 400 billion
base pairs per day and up to 12 human genome sequences
Conclusion
and 1.5 terabytes of data per 3.5-day run (Illumina 2015),
Big data will profoundly affect R&D, changing both what
providing access to larger amounts of genomic data faster
innovation looks like and how it is managed. We are
than ever before—and increasing the computing power
already seeing this impact. Although R&D has not generally
needed to gather insight from that data.
been at the forefront of big data applications, companies are
These capabilities are rapidly informing, enabling, and
starting to exploit these capabilities. GE’s heavy investment
transforming pharmaceutical R&D in a number of ways:
in data analytics for its aircraft engine unit and other
. Informing. The power to rapidly generate genetic data has businesses (Winig 2016) is one manifestation of that trend.
been harnessed in the UK’s 100,000 Genomes Project, Looking at the evolution in companies like GE, which are
which is sequencing entire genomes from a diverse set of early adopters of big data approaches, can give some sense
subjects, including patients with rare diseases. The resulting of how the future might unfold for R&D in all industries.
knowledge and insight should help clinicians to improve We believe that the framework we developed for this
diagnosis and outcomes (Genomics England n.d.). This study can be used as a guide in considering the impact
is but one project that uses such approaches. The big data is likely to have in a given industry. Further devel-
resulting torrent of data, when linked with information opment of this framework could lead to a maturity model to